Articles From: Idera Provides Key Updates on Clinical Development of IMO-8400 for Treatment of Waldenstrom's Macroglobulinemia to NephroGenex, MiMedx in focus for Wednesday


2014/12/30
- FDA grants Orphan Drug Designation for IMO-8400 for the treatment of Waldenström's macroglobulinemia - Four-week safety review by Data Review Committee for second dose cohort completed in ongoing WM trial; Third dose cohort opened for enrollment CAMBRIDGE, Mass., Dec.
Sign-up for Idera Provides Key Updates on Clinical Development of IMO-8400 for Treatment of Waldenstrom's Macroglobulinemia investment picks
2014/12/30
Focus on enabling computer literacy BANGALORE, India , December 30, 2014 /PRNewswire/ -- Infosys today announced that it would expand its Corporate Social Responsibility (CSR) activities in the Americas through its philanthropic arm, the Infosys Foundation, USA .
Sign-up for Infosys Expands its CSR Activities With Infosys Foundation, USA investment picks
2014/12/30
ADVISORY, Dec.
Sign-up for International Rescue Committee to Ring The Nasdaq Stock Market Closing Bell investment picks
2014/12/30
PHOENIX, Dec.
Sign-up for Inventure Foods to Present at the 17th Annual ICR XChange Conference investment picks
2014/12/30
Glancy Binkow & Goldberg LLP announces that it is investigating potential claims on behalf of investors of Sanofi (the “Company”) (NYSE:SNY) concerning possible violations of federal securities laws.
Sign-up for INVESTOR ALERT: Investigation on Behalf of Investors of Sanofi Announced by Glancy Binkow & Goldberg LLP investment picks
2014/12/30
Glancy Binkow & Goldberg LLP reminds investors of Salix Pharmaceuticals, Ltd.
Sign-up for INVESTOR ALERT: Investors of Salix Pharmaceuticals, Ltd. With Losses of $100,000 or More Are Encouraged to Contact Glancy Binkow & Goldberg LLP investment picks
2014/12/30
VANCOUVER , Dec.
Sign-up for Ivanhoe Energy receives an additional US$540,000 short-term loan from Robert Friedland investment picks
2014/12/30
By Laura He, MarketWatch Other major Asian markets close broadly lower HONG KONG (MarketWatch) -- Japan stocks declined on Tuesday, the last trading day of 2014, but gave the year a bullish end, marking a third straight year of gains.
Sign-up for Japan stocks decline, but mark a third yearly gain investment picks
2014/12/30
NEW BRUNSWICK, N.J. , Dec.
Sign-up for Johnson & Johnson to Participate in 33rd Annual JP Morgan Health Care Conference investment picks
2014/12/30
By Tom Corrigan A bankruptcy judge on Tuesday approved a $26 million tax settlement between Atlantic City, N.J., and the boardwalk's shuttered Revel Casino Hotel.
Sign-up for Judge approves $26 million Revel tax settlement investment picks
2014/12/30
BEIJING , Dec.
Sign-up for KongZhong Corporation Announces Strategic Investment in Forgame Holdings Limited investment picks
2014/12/30
KS Bancorp, Inc., the parent company of KS Bank, Inc., announced today that it has completed the redemption of all of its outstanding Fixed Rate Cumulative Perpetual Preferred Stock, Series A and Series B.
Sign-up for KS Bancorp Inc. Completes Repurchase of Preferred Stock and Private Placement of Subordinated Debt investment picks
2014/12/30
Liberty Interactive Corporation (Nasdaq: QVCA, QVCB, LVNTA, LVNTB) announced that Greg Maffei, President and CEO of Liberty Interactive Corporation, will be presenting at the Citi Global Internet, Media and Telecommunications Conference, on Wednesday, January 7th at 12:30 p.m., P.S.T. (3:30 p.m., E.S.T.) at the Bellagio Hotel in Las Vegas, NV.
Sign-up for Liberty Interactive Corporation to Present at the Citi Global Internet, Media and Telecommunications Conference investment picks
2014/12/30
Liberty Media Corporation (Nasdaq: LMCA, LMCB, LMCK) announced that Greg Maffei, President and CEO of Liberty Media Corporation, will be presenting at the Citi Global Internet, Media and Telecommunications Conference, on Wednesday, January 7 th at 12:30 p.m., P.S.T. (3:30 p.m., E.S.T.) at the Bellagio Hotel in Las Vegas, NV.
Sign-up for Liberty Media Corporation to Present at the Citi Global Internet, Media and Telecommunications Conference investment picks
2014/12/30
Liberty TripAdvisor Holdings, Inc. (Nasdaq: LTRPA, LTRPB) announced that Greg Maffei, President and CEO of Liberty TripAdvisor Holdings, Inc., will be presenting at the Citi Global Internet, Media and Telecommunications Conference, on Wednesday, January 7th at 12:30 p.m., P.S.T. (3:30 p.m., E.S.T.) at the Bellagio Hotel in Las Vegas, NV.
Sign-up for Liberty TripAdvisor Holdings, Inc. to Present at the Citi Global Internet, Media and Telecommunications Conference investment picks
2014/12/30
Lime Energy Co.
Sign-up for Lime Energy Raises $10 Million to Fund Growth investment picks
2014/12/30
Mace Security International, Inc. is pleased to announce that it and Merlin Partners, the holder of its 6% Convertible Debenture (due 3/31/16 and currently convertible at $0.192 per share), have agreed on a repurchase of the debenture.
Sign-up for Mace Security to Replace Convertible Debt with Less Costly Stand-by Financing investment picks
2014/12/30
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1166882&ProfileId=051205&sourceType=1 IRVINE, CA --
Sign-up for Masimo to Present at 33rd Annual J.P. Morgan Healthcare Conference investment picks
2014/12/30
By Philip van Doorn, MarketWatch The activist investor is setting his sights on industrial conglomerate Manitowoc Co.
Sign-up for Maybe Carl Icahn should try to break up these companies too investment picks
2014/12/30
Media General, Inc. (“Media General”; NYSE:MEG), one of the nation’s largest multimedia companies, announced today it is accepting applications for its Minority Scholarship and Training Program until January 30, 2015.
Sign-up for Media General Announces Minority Scholarship and Training Program for Students Pursuing Degrees in Broadcast Television and Digital Media investment picks
2014/12/30
OWINGS MILLS, Md.
Sign-up for Medifast, Inc. to Participate in the 17th Annual ICR XChange Conference investment picks
2014/12/30
HSINCHU, Dec.
Sign-up for MERGER UPDATE: ChipMOS' SUBSIDIARIES APPROVE MERGER AGREEMENT investment picks
2014/12/30
COMPANY REPORTS THAT ITS 4TH QUARTER AND FULL YEAR 2014 REVENUES WILL EXCEED UPPER END OF FORECAST MARIETTA, Ga.
Sign-up for MiMedx Comments On Recent FDA Draft Guidance On Minimal Manipulation Of HCT/Ps investment picks
2014/12/30
The Mississippi Board of Psychology is pleased to announce two new online payment services now available for licensed psychologists.
Sign-up for Mississippi Board of Psychology Launches Two New Online Services investment picks
2014/12/30
NephroGenex, Inc. (Nasdaq:NRX), a pharmaceutical company focused on the development of therapeutics to treat kidney disease, today announced the Company has successfully completed a thorough QT/QTc (TQT) cardiac safety study on Pyridorin.
Sign-up for NephroGenex Announces Positive Results for QT Study of Pyridorin investment picks
2014/12/30
By Wallace Witkowski, MarketWatch SAN FRANCISCO (MarketWatch) -- There are a few stocks that are expected to see action on Wednesday.
Sign-up for NephroGenex, MiMedx in focus for Wednesday investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Idera Provides Key Updates on Clinical Development of IMO-8400 for Treatment of Waldenstrom's Macroglobulinemia to NephroGenex, MiMedx in focus for Wednesday
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent